Full View

Evaluation of the Khorana, PROTECHT, and 5‐SNP scores for prediction of venous thromboembolism in patients with cancer

NAM Guman, RJ van Geffen, FI Mulder… - … of Thrombosis and …, 2021 - Wiley Online Library
Abstract Background The Khorana score is a validated tool to identify cancer patients at
higher risk of venous thromboembolism (VTE). Objective We compared its predictive …
被引用次数：21 相关文章
[HTML] nih.gov

[HTML][HTML] Evaluation of the Khorana, PROTECHT, and 5‐SNP scores for prediction of venous thromboembolism in patients with cancer

NAM Guman, RJ van Geffen, FI Mulder… - … of Thrombosis and …, 2021 - ncbi.nlm.nih.gov
Background The Khorana score is a validated tool to identify cancer patients at higher risk of
venous thromboembolism (VTE). Objective We compared its predictive performance to that …

Evaluation of the Khorana, PROTECHT, and 5-SNP scores for prediction of venous thromboembolism in patients with cancer

NAM Guman, RJ van Geffen… - … of thrombosis and …, 2021 - pubmed.ncbi.nlm.nih.gov
Background The Khorana score is a validated tool to identify cancer patients at higher risk of
venous thromboembolism (VTE). Objective We compared its predictive performance to that …

Evaluation of the Khorana, PROTECHT, and 5-SNP scores for prediction of venous thromboembolism in patients with cancer

NAM Guman, RJ van Geffen… - Journal of …, 2021 - researchinformation.amsterdamumc …
Background: The Khorana score is a validated tool to identify cancer patients at higher risk
of venous thromboembolism (VTE). Objective: We compared its predictive performance to …
[HTML] sciencedirect.com

[HTML][HTML] Evaluation of the Khorana, PROTECHT, and 5‐SNP scores for prediction of venous thromboembolism in patients with cancer

NAM Guman, RJ van Geffen, FI Mulder… - Journal of Thrombosis …, 2021 - Elsevier
Abstract Background The Khorana score is a validated tool to identify cancer patients at
higher risk of venous thromboembolism (VTE). Objective We compared its predictive …

Evaluation of the Khorana, PROTECHT, and 5-SNP scores for prediction of venous thromboembolism in patients with cancer.

NAM Guman, RJ van Geffen, FI Mulder… - … of Thrombosis and …, 2021 - europepmc.org
Background The Khorana score is a validated tool to identify cancer patients at higher risk of
venous thromboembolism (VTE). Objective We compared its predictive performance to that …

Evaluation of the Khorana, PROTECHT, and 5-SNP scores for prediction of venous thromboembolism in patients with cancer

NAM Guman, RJ van Geffen… - Journal of …, 2021 - cris.maastrichtuniversity.nl
Background The Khorana score is a validated tool to identify cancer patients at higher risk of
venous thromboembolism (VTE). Objective We compared its predictive performance to that …

Evaluation of the Khorana, PROTECHT, and 5-SNP scores for prediction of venous thromboembolism in patients with cancer

NAM Guman, RJ van Geffen, FI Mulder… - Journal of Thrombosis …, 2021 - elibrary.ru
Evaluation of the Khorana, PROTECHT, and 5-SNP scores for prediction of venous
thromboembolism in patients with cancer КОРЗИНА ПОИСК НАВИГАТОР ЖУРНАЛЫ КНИГИ …

Evaluation of the Khorana, PROTECHT, and 5‐SNP scores for prediction of venous thromboembolism in patients with cancer

NAM Guman, RJ van Geffen, FI Mulder… - Journal of Thrombosis …, 2021 - jthjournal.org
Abstract Background The Khorana score is a validated tool to identify cancer patients at
higher risk of venous thromboembolism (VTE). Objective We compared its predictive …